CXD101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CXD101, covering 2019-06-21 to 2025-03-21. Get the full timeline:
Most recent: Clinical Trial Update: CXD101 in Immunotherapy-related Liver Cancer [Phase 2]